Search

Compugen Ltd

Atidarymo kaina

2.4

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.39

Max

2.46

Pagrindiniai rodikliai

By Trading Economics

Pajamos

663K

-7M

Pardavimai

426K

2.6M

P/E

Sektoriaus vid.

6.526

56.432

Pelnas, tenkantis vienai akcijai

-0.07

Pelno marža

-269.254

Darbuotojai

75

EBITDA

665K

-7M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+107.47% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-09

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

9.8M

235M

Ankstesnė atidarymo kaina

2.4

Ankstesnė uždarymo kaina

2.4

Compugen Ltd Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-09-15 23:56; UTC

Akebia Therapeutics Inc shares are higher in after-market trading. Broader market sentiment is affected by a sharp decline in the NY Empire State Manufacturing Index.

2026-09-15 23:56; UTC

Fastly Inc. shares declined after-market, influenced by negative sentiment from the NY Empire State Manufacturing Index's sharp fall. The stock settled lower after a brief recovery.

2026-09-15 23:56; UTC

News

Lululemon Athletica shares are lower in after-market hours amid an investigation into potential securities law violations following a revenue guidance cut.

2026-09-15 23:56; UTC

eHealth Inc. shares were little changed in after-market hours. Broader market sentiment weakened following a significant decline in the NY Empire State Manufacturing Index.

2026-09-15 23:56; UTC

Maxlinear Inc shares are lower in after-market hours, pressured by a sharp decline in the NY Empire State Manufacturing Index, raising economic concerns.

2026-09-15 23:56; UTC

DaVita Inc shares are lower in after-market trading amid negative sentiment following a sharp decline in the NY Empire State Manufacturing Index.

2026-09-15 23:56; UTC

Textron Inc shares are higher in after-market trading, reaching a peak gain following the NY Empire State Manufacturing Index's sharp decline to 7.6 for September.

2026-09-15 23:56; UTC

Bandwidth Inc. shares declined in after-market hours, reflecting negative sentiment tied to a sharp drop in the NY Empire State Manufacturing Index.

2026-09-15 23:52; UTC

Japan's August trade deficit hits -1052.6 billion yen amid ongoing economic challenges and weak yen concerns, raising questions on future monetary policy.

2026-09-15 23:52; UTC

Japan's Exports Expected to Rise 0.182% YoY Amid Cautious Optimism in Global Trade Dynamics

2026-09-15 23:52; UTC

Japan's Machinery Orders Expected to Decline by 2.8% in September, Raising Concerns Over Capital Spending and Business Investment

2026-09-15 23:52; UTC

US Business Inventories MoM Data Release on September 16 Expected to Show Modest 0.3% Increase Amid Inflation and Interest Rate Concerns.

2026-09-15 23:52; UTC

Brazil's Central Bank to announce interest rate decisions on September 21, amid global focus on central bank policies and inflation concerns.

2026-09-15 23:52; UTC

NAHB Housing Market Index for September 2026 Expected at 34.0 Amid Ongoing Builder Confidence Concerns and Slowing Home Construction

2026-09-15 23:52; UTC

U.S. Industrial Production Expected to Rise 0.3% in September Amid Mixed Economic Signals and Global Concerns

2026-09-15 23:51; UTC

Innovative Industrial Properties Inc shares are higher in after-market hours, though no specific company news was identified to explain the movement.

2026-09-15 23:51; UTC

Box Inc shares are higher in after-market hours, continuing a trend of higher closes over the last three sessions. No specific news was identified.

2026-09-15 23:51; UTC

Correlated Moves

Shares of Sunrun Inc. declined in after-market trading, diverging from recent trends amid mixed economic data and rising U.S. crude oil inventories.

2026-09-15 23:51; UTC

Progressive Corp shares declined during after-market hours, reaching a low of -0.61%. No specific news was identified to explain the price movement.

2026-09-15 23:51; UTC

Correlated Moves

Ross Stores Inc shares are higher in after-market trading, reflecting positive sentiment linked to TJX Companies Inc's performance amid increased after-hours activity.

2026-09-15 23:51; UTC

CytomX Therapeutics Inc shares are higher in after-market hours, though no specific news explains the movement. This marks a shift from recent trends.

2026-09-15 23:51; UTC

Under Armour Inc shares are lower in after-market trading, continuing declines amid inflation concerns linked to rising U.S. crude oil inventories.

2026-09-15 23:51; UTC

Minerals Technologies Inc shares are lower in after-market hours, with no specific news identified. The stock remains below its 20-day moving average.

2026-09-15 23:51; UTC

Editas Medicine Inc shares are higher in after-market trading. No specific company news was identified to explain this price movement.

2026-09-15 23:51; UTC

Correlated Moves

Raymond James Financial shares are higher in after-market trading, aligning with Bank of America's performance despite mixed broader market sentiment.

2026-09-15 23:51; UTC

T-Mobile US Inc shares are higher in after-market hours, continuing a recent upward trend from earlier lows. No specific news was identified for the movement.

2026-09-15 23:46; UTC

Insight Enterprises Inc shares are higher in after-market trading, advancing slightly since Tuesday's close. The stock is positioned above its 20-day moving average.

2026-09-15 23:46; UTC

California Water Service Group shares were roughly flat in after-market hours, remaining about 3.74% below their 20-day moving average.

2026-09-15 23:46; UTC

LeMaitre Vascular Inc. shares are higher in after-market trading, moving within a narrow range since Tuesday's close and remaining near the lower end of their monthly range.

2026-09-15 23:46; UTC

Essential Utilities Inc shares are higher in after-market hours, remaining near the upper end of their one-month trading range. No specific news was identified.

Akcijų palyginimas

Kainos pokytis

Compugen Ltd Prognozė

Kainos tikslas

By TipRanks

107.47% į viršų

12 mėnesių prognozė

Vidutinis 5 USD  107.47%

Aukščiausias 6 USD

Žemiausias 4 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Compugen Ltd kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

2

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.
help-icon Live chat